Home LKC Technologies Superior Diabetic Retinopathy Progression Risk Assessment
LKC Technologies

Superior Diabetic Retinopathy Progression Risk Assessment

Predicting which patients will need treatment for diabetic retinopathy (DR) requires the ability to better manage risk progression – which is possible when you add objective, functional testing to your existing structural assessments. Learn how.

Read more about LKC Technologies on using modern ERG

or glaucoma management.

 

Previous articleNearly Every State Saw Increases in Percentage of Women ODs
Next articleMeet Mahle, the Friendly Practice Mascot

RELATED ARTICLES

LKC Technologies

From Urban Academia to Rural Private Practice: How Two ODs are Using Handheld ERG to Embrace New Guidance from the Diabetic Retinopathy Taskforce

In September 2023, an important news release announced a consensus document, developed by a special task force made up of optometrists who have a...
Read more
LKC Technologies

The Five Pillars of Diabetic Retinopathy Management in Optometry

DETECT: Approach diabetic retinopathy as a chronic progressive disease. Being a chronic progressive disease implies that you can detect it before it becomes...
Read more
LKC Technologies

Task Force Releases Consensus Document for Managing Diabetic Retinopathy in Optometry

LKC Technologies, a leader in functional testing using electroretinography (ERG), has released a new report on diabetic retinopathy (DR).  Modern Fundamentals of Diabetic Retinopathy...
Read more
- Advertisment -

Most Popular

Poll Respondents Prefer Summer Temps All Year Long

Polls
As many optometric offices prep for fall weather, WO asked readers who is in charge of adjusting the thermostat in the office. ALL ABOUT PREFERENCE The majority...
Read more

Before Recommending Vitamin D Supplements, Know Where the Patient Is

Building a Specialty
Vitamin D is clearly a beneficial vitamin, but there is too much of a good thing. There are risks to vitamin D levels that...
Read more

Women Under-represented in Top Business Slots

News
Although 10.6% of Fortune 500 CEO slots are held by women and 30.4% of board positions are, most Americans feel that women are under-represented...
Read more

Game-Changing N3 VR Headset Announced in New Neurolens/Jobson Special Report

New
Neurolens and Jobson Medical Information have jointly released a new eight-page report announcing the launch of the game-changing virtual reality N3 headset that measures...
Read more
Load more

Womeninoptometry.com

Jobson Optical Group

More

Copyright © 2020 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.

MORE STORIES

The Three Biggest Ways ERG Changed My Practice

From Urban Academia to Rural Private Practice: How Two ODs are...